SPONSORED CONTENT
TIP: Evaluate the downstream impact of every operational change before implementation.
In today’s 340B landscape, seemingly small operational updates can create significant unintended consequences. A covered entity’s (CE) program can quickly take a turn if impact is not appropriately assessed and addressed prior. Manufacturer restrictions, legal developments and program requirements will continue to shift, and CEs are required to ingest more information now than ever.
CEs need to be prepared to approach these operational changes with careful review and collaboration from internal and external stakeholders. CEs should evaluate and understand the request first and then engage internal and external stakeholders as appropriate to be a part of the decision-making process. A formal impact analysis may even be necessary to make an informed decision that reviews how pricing access and claim qualification rate might be impacted. A proactive approach can help protect both compliance and long-term operational performance.
340B operations can become complex quickly and decisions should never be made in a silo. Collaboration with vendors such as your third-party administrator (TPA) and proactive evaluation are essential to maintaining program integrity and operational efficiency. For more operational bright spots, be sure to connect with us at 340B Coalition Summer Conference in July!
Kaitlyn Weckhorst, Account Executive at SunRx, can be reached at kweckhorst@sunrx.com
